Stockscreener 앱 받기
7.2557
3.13%
0.2257
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Bank of New York Mellon Corp Purchases 77,510 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
Jupiter Asset Management Ltd. Sells 88,555 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Gap Up to $6.58 - MarketBeat
How the (AUPH) price action is used to our Advantage - Stock Traders Daily
Aurinia Pharmaceuticals reshuffles board, adds new director By Investing.com - Investing.com Australia
Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference - Business Wire
Aurinia Pharmaceuticals (AUPH) Stock Gains After Hours Following Board Realignment - Stocks Telegraph
Aurinia Pharmaceuticals reshuffles board, adds new director - Investing.com
Aurinia Pharmaceuticals Announces Board Restructuring and Director Changes - TipRanks
Aurinia Pharmaceuticals reshuffles board, adds new director - Investing.com India
Aurinia Announces Board Restructuring - Business Wire
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 3.2% - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 3.3% - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Aurinia Pharmaceuticals (NASDAQ:AUPH) - MarketBeat
H.C. Wainwright reiterates Buy rating on Aurinia Pharma shares - Investing.com
Aurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseases - Clinical Trials Arena
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Surges 30% Yet Its Low P/S Is No Reason For Excitement - Simply Wall St
Traders Purchase High Volume of Aurinia Pharmaceuticals Call Options (NASDAQ:AUPH) - MarketBeat
Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial - sharewise
Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial - Business Wire
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - Manchestertimes
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 13.8% in August - MarketBeat
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - sharewise
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 2.4% - MarketBeat
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Passes Above 50-Day Moving Average of $5.73 - MarketBeat
Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't? - MSN
Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't? - Yahoo Finance
Aurinia Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AUPH) - MarketBeat
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 5.4% - Defense World
(AUPH) Technical Pivots with Risk Controls - Stock Traders Daily
Price T Rowe Associates Inc. MD Increases Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Up 13.1% in July - MarketBeat
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock Position Raised by Vanguard Group Inc. - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 5.4% - MarketBeat
Cetera Advisors LLC Has $301,000 Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
California State Teachers Retirement System Trims Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals faces boardroom shakeup demand By Investing.com - Investing.com Australia
Aurinia Pharmaceuticals faces boardroom shakeup demand - Investing.com
This Insider Has Just Sold Shares In Aurinia Pharmaceuticals - Simply Wall St
AUPHAurinia Pharmaceuticals Inc. Latest Stock News & Market Updates - StockTitan
The growth track for Aurinia Pharmaceuticals Inc (AUPH) has changed recently - SETE News
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Sold by DekaBank Deutsche Girozentrale - Defense World
Scott Michael Habig Sells 18,249 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock - Defense World
Scott Michael Habig Sells 18,249 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock - MarketBeat
Investor’s Delight: Aurinia Pharmaceuticals Inc (AUPH) Closes Weak at 5.32, Down -5.34 - The Dwinnex
Virtu Financial LLC Takes Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Long Term Trading Analysis for (AUPH) - Stock Traders Daily
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) to Post Q1 2025 Earnings of $0.05 Per Share, Leerink Partnrs Forecasts - MarketBeat
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Forecasted to Post Q1 2025 Earnings of $0.05 Per Share - Defense World
Analysts Issue Forecasts for Aurinia Pharmaceuticals Inc.’s Q3 2024 Earnings (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Issues Earnings Results - Defense World
Aurinia Pharmaceuticals (NASDAQ:AUPH) Releases Earnings Results, Meets Estimates - MarketBeat
Aurinia Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Aurinia Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
State Board of Administration of Florida Retirement System Sells 10,890 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript - Insider Monkey
Aurinia: Q2 Earnings Snapshot - San Antonio Express-News
Aurinia Pharmaceuticals, Inc. (AUPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
Aurinia: Q2 Earnings Snapshot - The Washington Post
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results - sharewise
Aurinia Pharmaceuticals (AUPH) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Aurinia Pharmaceuticals Files SEC Report, Shares Trade on Nasdaq - TipRanks
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results - wallstreet:online
1.25%
1.94%
자본화:
|
볼륨(24시간):